LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Dec 12, 2023
Distillery Therapeutics
MANF for inherited kidney disease
Read More
BioCentury
|
Oct 1, 2021
Distillery Therapeutics
Inducing ferroptosis in cancer cells by inhibiting SLC40A1 and LCN2
Read More
BioCentury
|
Apr 29, 2021
Distillery Therapeutics
Inhibiting RNA epigenetic enzyme METTL3 for polycystic kidney disease
DISEASE CATEGORY: Renal
INDICATION: Polycystic kidney disease (PKD) Targeting METTL3, which creates N6-methyladenosine (m6A) modifications on RNA, could treat autosomal dominant polycystic
Read More
BioCentury
|
Aug 29, 2019
Distillery Therapeutics
Tumor-targeted nanoparticle delivery of gene editing therapy for breast cancer
Read More
BioCentury
|
Aug 28, 2019
Translation in Brief
Nanoparticles targeting CRISPR to cancer
Boston Children’s team’s system targets gene editing therapies to triple negative breast cancer cells
Read More
BioCentury
|
Oct 26, 2018
Politics & Policy
FDA grants first qualification of a clinical safety biomarker
Read More
BioCentury
|
Jun 14, 2017
Distillery Techniques
Assays and screens
Read More
BioCentury
|
Mar 16, 2017
Targets & Mechanisms
Bone appétit!
How a bone hormone could help treat obesity
Read More
BioCentury
|
Mar 15, 2017
Distillery Therapeutics
Endocrine / Metabolic
Read More
BioCentury
|
Jan 12, 2017
Translation in Brief
Iron age arms race
Fighting bacteria with their own defensive molecules
Read More
Items per page:
10
1 - 10 of 47